| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.17 | 0.6 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |